Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000712980 | SCV000843540 | uncertain significance | not provided | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002534515 | SCV003273261 | benign | Spastic paraplegia | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002534514 | SCV003629478 | uncertain significance | Inborn genetic diseases | 2022-07-19 | criteria provided, single submitter | clinical testing | The c.6178G>C (p.V2060L) alteration is located in exon 10 (coding exon 9) of the SACS gene. This alteration results from a G to C substitution at nucleotide position 6178, causing the valine (V) at amino acid position 2060 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001830584 | SCV002086243 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2020-12-21 | no assertion criteria provided | clinical testing |